The clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction

The clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction - Heart failure with preserved ejection fraction and serum magnesium

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032347

Enrollment

500

Registered

2018-04-29

Start date

2008-01-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure with preserved ejection fraction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with heart failure who were hospitalized in Kumamoto University Hospital

Exclusion criteria

Exclusion criteria: Do not meet diagnostic criteria for heart failure with preserved ejection fraction Severe valvular disease Active infection diseases End stage of chronic kidney diseases

Design outcomes

Primary

Measure	Time frame
Composite endopoint of cardiovascular death, non-fatal myocardial infarction, unstable anginapectoris, non-fatal stroke, or re-hospitalization for heart failure	—

Countries

Japan

Contacts

Public ContactTaiki Nishihara

Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine

t-nishi@kumamoto-u.ac.jp81-96-373-5175

Outcome results